StreetAlpha
13F holdings · Q3 2026

Mass General Brigham

Somerville, MA · files as Mass General Brigham, Inc
Know the moment Mass General Brigham filesYou follow Mass General Brigham An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 3, 2026Next filing due Feb 15, 2027CIK 1678378

Mass General Brigham reported 9 stocks worth $456M in its 13F filing for Q3 2026, filed Nov 3, 2026. Its largest holdings are VT (65.8%), RVMD (15.5%) and SPCX (7.7%). Compared with Q2 2026, the fund opened new positions in VT, SPCX and LYNX, added to MAZE, trimmed KRMN and sold out of ACWI.

Latest filing: what Mass General Brigham did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new1 added1 trimmed1 sold outBought about $361M · sold about $242M
New 4
Added 1
Trimmed 1
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$456M+26.4% vs last quarter
Stocks held94 new · 1 sold out
Top 5 weight96.2%very concentrated
Turnover132%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 4 qtrsHeld
1
VT
Vanguard Total World
$300M65.8%1.9MNew position1 of 4
2
RVMD
Revolution Medicines Inc
$70.6M15.5%344KNo change4 of 4
3
SPCX
Space Exploration Techn Corp Class A Com Stk
$35.3M7.7%234KNew position1 of 4
4
LYNX
Lyntris Inc
$23.6M5.2%1.9MNew position1 of 4
5
TNGX
Tango Therapeutics Inc
$8.8M1.9%354KNo change4 of 4
6
MAZE
Maze Therapeutics Inc
$6.8M1.5%250K+9,642 (+4%)4 of 4
7
KRMN
Karman Hldgs Inc
$6.8M1.5%209K−1.4M (−87%)4 of 4
8
MDLN
Medline Inc
$2.4M0.5%68KNo change4 of 4
9
IOT
Samsara Inc
$1.5M0.3%40KNew position1 of 4

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ACWI
Ishares TR
$198M1.3M

Reported value

last 4 quarters
$810MQ4 '25
$469MQ1 '26
$361MQ2 '26
$456MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 3, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Mass General Brigham 13F FAQ

What does Mass General Brigham own?

Mass General Brigham reported 9 stocks worth $456M in its 13F filing for Q3 2026, filed Nov 3, 2026. Its largest holdings are VT (65.8%), RVMD (15.5%) and SPCX (7.7%). The table above lists every position in the filing (the top 10 without an account).

What did Mass General Brigham buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 1 added to, 1 trimmed and 1 sold out. New positions include VT, SPCX and LYNX. It sold all of ACWI.

When will Mass General Brigham file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Mass General Brigham's portfolio worth?

The Q3 2026 filing reports $456M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.